| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
ACTA Pharmaceutica Sciencia
2022 , Vol 60 , Num 2
In vitro ACE2 Enzyme Inhibitory Activity Evaluation of Different Salvia Essential Oils
1 Department of Pharmacognosy, School of Pharmacy, Istanbul Medipol University, 34810, Istanbul, TURKEY2 Depatment of Pharmacognosy, Graduate School of Health Sciences, Anadolu University, Eskişehir , TURKEY
3 Department of Pharmaceutical Microbiology, School of Pharmacy, Istanbul Medipol University, 34810-Beykoz, Istanbul, Turkey
4 Institute of Sciences, Istanbul University, 34116-Istanbul, Turkey
5 Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, 26470-Eskişehir, Turkey
6 Faculty of Pharmacy, Eastern Mediterranean University, 99450-Famagusta, N. Cyprus, Mersin 10, Turkey
DOI : 10.23893/1307-2080.APS.6008 Viewed : 14941 - Downloaded : 4040 In this present study, commertially available Salvia triloba L., S.officinalis L., and S. sclarea L. essential oils were evaluated for their in vitro angiotensin converting enzyme 2 (ACE2) inhibitory activity. The Salvia essential oils compositions were confirmed both by GC-FID and GC/MS. Main components of the S. triloba essential oil was characterized as 1,8-cineole (22.8%), camphor (17.2%), ?-thujone (15.2 %), ?-caryophyllene (11.4 %), and ?-humulene (3%). Major constiutents were identified as ?-thujone (28.5 %), camphor (20.6 %), 1,8-cineole (10.9%), ?-humulene (5%), and camphene (4.9 %) in S. officinalis essential oil. Whereas, linalylacetate (56.8 %), linalool (21.1%), ?-terpineol (6.1%), geraniol (5%), and ?-caryophyllene (3.4%) were the major components of S. sclarea essential oil. The essential oils were evaluated using a fluorometric multiplate based enzyme inhibition kit, where the ACE2 inhibitions of S. triloba, S. officinalis, and S. sclarea essential oils were 50.1%, 60.5%, and 72.1% at a concentration of 20 µg/mL, respectively. As a result, further tests of Salvia essential oils supported by in vivo studies may have antiviral potential applications against coronaviruses due to ACE2 enzyme inhibitions. Keywords : Salvia, coronavirus, ACE2, essential oil